OR7E84P: A Protein Implicated in Cancer, Neurodegenerative Disorders and Cardiovascular Disease
OR7E84P: A Protein Implicated in Cancer, Neurodegenerative Disorders and Cardiovascular Disease
OR7E84P, also known as OR7E54P, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its primary function is to help regulate the transport of oxygen and nutrients to the cells in the body. OR7E84P is a key player in the regulation of cell signaling pathways, and its levels have been linked to a number of diseases, including cancer, neurodegenerative disorders, and cardiovascular disease. As a drug target, OR7E84P is of interest to researchers because it provides a potential target for new treatments.
OR7E84P is a member of the superfamily of transmembrane protein (SMP)s, which are a type of gene product that is expressed in the cell membrane. SMPs are involved in a wide range of cellular processes, including signal transduction, ion transport, and cell signaling. OR7E84P is specifically characterized by its ability to interact with the protein p21 (TNFAIP3), which is also known as AP-1.
The p21 protein is a key regulator of cell growth and division. It is a transcription factor that has been implicated in the development and progression of many diseases, including cancer. p21 is also known for its ability to interact with the protein p53, which is a well-known tumor suppressor protein. When p21 and p53 interact, they can cause cells to enter a state of G1-phase, which is a stage of cell growth where the cell prepares for cell division.
OR7E84P is involved in the regulation of p21 and p53 interactions, and its levels have been linked to the development and progression of many diseases. For example, studies have shown that OR7E84P is overexpressed in many types of cancer, including breast, ovarian, and prostate cancer. This increase in OR7E84P levels has been observed in association with cancer progression and the development of cancer-initiating events.
In addition to its involvement in cancer, OR7E84P has also been linked to a number of other diseases, including neurodegenerative disorders and cardiovascular disease. For example, studies have shown that OR7E84P is overexpressed in the brains of individuals with Alzheimer's disease, a neurodegenerative disorder. This increase in OR7E84P levels has been observed in association with the development of neurodegenerate symptoms, including the loss of memory and cognitive decline.
OR7E84P has also been linked to cardiovascular disease. Studies have shown that OR7E84P is overexpressed in the hearts of individuals with heart disease, and this increase in OR7E84P levels has been observed in association with the development of cardiovascular disease. This may be because OR7E84P plays a role in the regulation of cardiovascular function, and its levels may be affected by conditions that affect cardiovascular health.
Despite its potential as a drug target, OR7E84P is not yet a well-studied protein. There are currently few research studies focused on the regulation of OR7E84P, and there is a lack of understanding of its role in many different diseases. As research continues to advance, it is likely that the role of OR7E84P in disease will become more clear.
In conclusion, OR7E84P is a protein that is expressed in various tissues of the body and is involved in the regulation of cell signaling pathways. Its levels have been linked to a number of diseases, including cancer, neurodegenerative disorders, and cardiovascular disease. As a drug target, OR7E84P is of interest to researchers because it provides a potential target for new treatments. Further research is needed to fully understand the role of OR7E84P in disease and to develop new treatments based on its properties.
Protein Name: Olfactory Receptor Family 7 Subfamily E Member 84 Pseudogene
The "OR7E84P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR7E84P comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1 | OR8J3 | OR8K1 | OR8K3 | OR8K5 | OR8S1 | OR8U1 | OR8U3 | OR8U8 | OR9A1P | OR9A2 | OR9A4 | OR9G1 | OR9G4 | OR9G9 | OR9H1P | OR9I1 | OR9K2 | OR9Q1 | OR9Q2 | ORAI1 | ORAI2 | ORAI3 | ORC1 | ORC2 | ORC3 | ORC4 | ORC5 | ORC6 | Orexin receptor | Organic anion transporters (OATs) | Organic cation transporter | Origin recognition complex | ORM1 | ORM2 | ORMDL1 | ORMDL2 | ORMDL3 | OS9 | OSBP | OSBP2 | OSBPL10 | OSBPL11 | OSBPL1A | OSBPL2 | OSBPL3 | OSBPL5 | OSBPL6 | OSBPL7 | OSBPL8 | OSBPL9 | OSCAR | OSCP1 | OSER1 | OSER1-DT | OSGEP | OSGEPL1 | OSGEPL1-AS1 | OSGIN1 | OSGIN2 | OSM | OSMR | OSMR-DT | OSR1 | OSR2 | OST4 | OSTC | OSTCP1 | OSTF1 | OSTF1P1 | OSTM1
